Traditional Chinese medicine for improving cardiac function

Abstract

The invention discloses a traditional Chinese medicine for improving a cardiac function. The traditional Chinese medicine is prepared from the following raw materials in parts by weight: 20-30 parts of elecampane, 12-18 parts of white semen pharbitidis, 12-18 parts of pyropolyporus formentarius teng, 8-19 parts of tortoise plastron, 15-25 parts of root of common peony, 8-15 parts of radix stephaniae tetrandrae and 15-20 parts of paris polyphylla. The drug disclosed by the invention is used for treating a heart disease, has the effects of strengthening the foundation, removing symptoms, and restoring and removing evil; conditioning a renal function is taken as a central link of treatment; meanwhile, coordination of functions of internal organs such as kidneys, heart, liver and spleen are emphasized, so that kidney yin is nourished; kidney qi is warmed up; vital energy and blood are nourished; extravasated blood is relieved; heat toxin can be cleared; the traditional Chinese medicine not only can reduce lipid, prevent coagulation, reduce blood viscosity and dissolve thrombus, but also can improve the vascular endothelial function, relieve vasospasm, prevent arteriosclerosis and stabilize vulnerable plaques, has dual treatment effects on blood and vessel lesions, and can effectively treat diseases of a cardiovascular system.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for improving heart function, belonging to the field of traditional Chinese medicine. Background technique [0002] Chronic rheumatic heart disease, also known as rheumatic valvular heart disease, referred to as rheumatic heart disease, refers to chronic heart valve damage caused by rheumatic fever, resulting in stenosis or insufficiency of the valve orifice, which in turn leads to changes in hemodynamics and develops into heart function. Insufficient compensation, the formation of congestive heart failure. The main clinical features are palpitations, dyspnea, cough, hemoptysis, and edema. The disease is more common in young adults aged 20 to 40, more women than men, and 50% to 70% of patients have a clear history of rheumatic fever. The most common valve involvement is mitral stenosis with regurgitation, recurrent rheumatic fever, leading to refractory heart failure, and infective endocarditis,...

AI Technical Summary

Problems solved by technology

For chronic rheumatic heart disease, Western medicine often adopts surgical treatment and valve replacement, but the cost of surgery is high and the risk is high, and ordinary patients cannot afford it